Canada-based TerrAscend, a biopharmaceutical and wellness company involved in the global cannabinoid market, has named Jeffrey J Puglisi as its new chief corporate officer, it was reported yesterday.
Puglisi will be responsible for the oversight and execution of the firm's US strategy.
Puglisi has been the executive vice president of Business Development and Corporate Affairs of the firm since December 2017. He has more than 30 years of experience in the capital markets and the securities industry. He co-founded Puglisi & Co. He also founded Puglisi Capital Partners LP.
Galapagos plans to wind down cell therapy business following strategic review
Sebela's MIUDELLA Hormone-Free Copper IUS recognised in TIME's best inventions of 2025
Revelation Pharma acquires Acacia Apothecary & Wellness
Viatris receives fifth consecutive recognition on Forbes' annual list of World's Best Employers
INOVIO announces inducement grant to new employee
AbbVie's Allergan Aesthetics announces Natrelle supplier agreement with Vizient
Karyopharm Therapeutics awards inducement grants to new employees
POLYTECH Health & Aesthetics announces Poland expansion
Santhera Pharmaceuticals signs Gulf region distribution agreement with Uniphar